| Neuroendocrine tumors, version 1.2015 MH Kulke, MH Shah, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 13 (1), 78-108, 2015 | 406 | 2015 |
| NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ... Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018 | 330 | 2018 |
| Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 308 | 2021 |
| γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation D Daley, CP Zambirinis, L Seifert, N Akkad, N Mohan, G Werba, R Barilla, ... Cell 166 (6), 1485-1499. e15, 2016 | 303 | 2016 |
| Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors TT Smith, HF Moffett, SB Stephan, CF Opel, AG Dumigan, X Jiang, ... The Journal of clinical investigation 127 (6), 2176-2191, 2017 | 285 | 2017 |
| Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition VG Pillarisetty, AB Shah, G Miller, JI Bleier, RP DeMatteo The Journal of Immunology 172 (2), 1009-1017, 2004 | 279 | 2004 |
| Neuroendocrine tumors MH Kulke, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, MA Choti, ... Journal of the National Comprehensive Cancer Network 10 (6), 724-764, 2012 | 253 | 2012 |
| Key chemokines direct migration of immune cells in solid tumors K Kohli, VG Pillarisetty, TS Kim Cancer gene therapy 29 (1), 10-21, 2022 | 249 | 2022 |
| T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas SM Pollack, Q He, JH Yearley, R Emerson, M Vignali, Y Zhang, ... Cancer 123 (17), 3291-3304, 2017 | 237 | 2017 |
| The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies KM Elias, AB Stone, K McGinigle, JAI Tankou, MJ Scott, WJ Fawcett, ... World journal of surgery 43 (1), 1-8, 2019 | 192 | 2019 |
| Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12 VG Pillarisetty, SC Katz, JI Bleier, AB Shah, RP DeMatteo The Journal of Immunology 174 (5), 2612-2618, 2005 | 191 | 2005 |
| Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma SK Daniel, KM Sullivan, KP Labadie, VG Pillarisetty Clinical and translational medicine 8, 1-17, 2019 | 185 | 2019 |
| T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases SC Katz, V Pillarisetty, ZM Bamboat, J Shia, C Hedvat, M Gonen, ... Annals of surgical oncology 16, 2524-2530, 2009 | 183 | 2009 |
| Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases SC Katz, ZM Bamboat, AV Maker, J Shia, VG Pillarisetty, AC Yopp, ... Annals of surgical oncology 20, 946-955, 2013 | 182 | 2013 |
| Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer YD Seo, X Jiang, KM Sullivan, FG Jalikis, KS Smythe, A Abbasi, M Vignali, ... Clinical Cancer Research 25 (13), 3934-3945, 2019 | 169 | 2019 |
| Role of immune cells in pancreatic cancer from bench to clinical application: an updated review JH Chang, Y Jiang, VG Pillarisetty Medicine 95 (49), e5541, 2016 | 159 | 2016 |
| The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies SK Daniel, YD Seo, VG Pillarisetty Seminars in cancer biology 65, 176-188, 2020 | 146 | 2020 |
| A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer CP Rodriguez, Q Wu, J Voutsinas, JR Fromm, X Jiang, VG Pillarisetty, ... Clinical Cancer Research 26 (4), 837-845, 2020 | 139 | 2020 |
| Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection G Miller, S Lahrs, VG Pillarisetty, AB Shah, RP DeMatteo Cancer research 62 (18), 5260-5266, 2002 | 139 | 2002 |
| Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment KC Shibuya, VK Goel, W Xiong, JG Sham, SM Pollack, AM Leahy, ... PloS one 9 (5), e96565, 2014 | 136 | 2014 |
